Intriguingly, data from the TGCA gastric cancer dataset (48) show that EBV-positive gastric cancer frequently exhibits amplification at 9p24.1, a locus containing CD274 and PDCD1LG2 (encoding PD-L1 and PD-L2), which is associated with a more immune-active profile. Here, CD274 is linked to gastric cancer.